Bridging Efficacy of a Tetravalent Dengue Vaccine from Children/Adolescents to Adults in Highly Endemic Countries Based on Neutralizing Antibody Response

The CYD-TDV vaccine is licensed in multiple endemic countries based on vaccine efficacy (VE) against symptomatic, virologically confirmed dengue demonstrated in two phase 3 trials (CYD14, 2- to 14-year-olds, Asia; CYD15, 9- to 16-year-olds, Latin America). 50% plaque reduction neutralization test (P...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Trop Med Hyg
Main Authors: Gilbert, Peter B., Huang, Ying, Juraska, Michal, Moodie, Zoe, Fong, Youyi, Luedtke, Alexander, Zhuang, Yingying, Shao, Jason, Carpp, Lindsay N., Jackson, Nicholas, Chambonneau, Laurent, Bouckenooghe, Alain, Zambrano, Betzana, Frago, Carina, Pallardy, Sophie, Noriega, Fernando
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society of Tropical Medicine and Hygiene 2019
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6609170/
https://ncbi.nlm.nih.gov/pubmed/31115304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.18-0534
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados